\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\\.\ \(14\)\
\-\ surgical\\ resection\ \(126\)\
\-\ film\\ \\#1\\:\\ non\\-enhanced\\ ct\\ image\\ shows\\ a\\ slightly\\ decreased\\ attenuating\\ focal\\ mass\\ in\\ the\\ pancreatic\\ body\\ with\\ diffuse\\ atrophic\\ changes\\.\\ several\\ enlarged\\ peripancreatic\\ lymph\\ nodes\\ are\\ present\\ with\\ the\\ largest\\ measuring\\ 13\\ mm\\ on\\ short\\ axis\\ diameter\\.\ \(0\)\
\-\ film\\ \\#2\\:\\ dynamic\\ contrast\\-enhanced\\ ct\\ image\\ shows\\ a\\ 2\\.5\\ x\\ 4\\.3\\ cm\\ unenhancing\\,\\ hypodense\\ mass\\ in\\ the\\ pancreatic\\ body\\.\\ no\\ metastases\\ were\\ seen\\ in\\ the\\ liver\\.\\ \ \(0\)\
\-\ film\\ \\#3\\:\\ dynamic\\ contrast\\-enhanced\\ ct\\ image\\ \\(on\\ liver\\ window\\)\\ shows\\ a\\ 7\\ mm\\ obstructed\\ pancreatic\\ duct\\ \\(arrow\\)\\ surrounded\\ by\\ contrast\\-enhanced\\ pancreatic\\ parenchyma\\ seen\\ distal\\ to\\ the\\ pancreatic\\ mass\\.\ \(0\)\
\-\ pancreatic\\ ductal\\ adenocarcinoma\ \(0\)\
\-\ 1\\.\\)most\\ exocrine\\ pancreatic\\ tumors\\;\\ 2\\.\\)lymphoma\\;\\ 3\\.\\)pancreatic\\ endocrine\\ tumors\\ \\(mostly\\ non\\-functional\\)\\.\ \(0\)\
\-\ 56\\ year\\ old\\ male\\ with\\ severe\\ upper\\ abdominal\\ pain\\,\\ left\\ greater\\ than\\ right\\,\\ for\\ 1\\ week\\.\ \(1\)\
\-\ a\\ majority\\ of\\ non\\-endocrine\\ pancreatic\\ carcinomas\\,\\ up\\ to\\ 75\\-85\\%\\,\\ are\\ ductal\\ cell\\ adenocarcinomas\\[1\\,2\\]\\.\\ the\\ tumor\\ is\\ highly\\ lethal\\ and\\ is\\ usually\\ unresectable\\ at\\ presentation\\.\\ the\\ average\\ survival\\ time\\ of\\ a\\ patient\\ with\\ this\\ disease\\ is\\ only\\ 8\\ months\\ or\\ less\\.\\ these\\ tumors\\ usually\\ occur\\ in\\ the\\ seventh\\ decade\\ of\\ life\\.\\ \\ \ \(0\)\
\-\ currently\\,\\ computed\\ tomography\\ \\(ct\\)\\ is\\ the\\ most\\ commonly\\ used\\ imaging\\ method\\ in\\ the\\ assessment\\ of\\ pancreatic\\ tumors\\.\\ the\\ sensitivity\\ of\\ ct\\ detection\\ of\\ pancreatic\\ tumors\\ is\\ reported\\ to\\ be\\ more\\ than\\ 90\\%\\ when\\ direct\\ or\\ indirect\\ signs\\ are\\ used\\ for\\ diagnosis\\[1\\]\\.\\ however\\,\\ the\\ potential\\ to\\ differentiate\\ exocrine\\ \\(non\\-endocrine\\)\\ tumors\\ of\\ the\\ pancreas\\ is\\ limited\\.\\ \ \(0\)\
\-\ on\\ non\\-enhanced\\ ct\\ imaging\\,\\ there\\ is\\ often\\ a\\ slightly\\ decreased\\ attenuating\\ pancreatic\\ mass\\ seen\\.\\ following\\ rapid\\ bolus\\ of\\ contrast\\ injection\\,\\ the\\ tumor\\ usually\\ appears\\ as\\ a\\ hypodense\\ mass\\ with\\ ill\\-defined\\ borders\\.\\ calcification\\ is\\ almost\\ never\\ present\\ within\\ the\\ mass\\.\\ indirect\\ signs\\ of\\ a\\ pancreatic\\ mass\\ include\\ abrupt\\ obstruction\\ of\\ the\\ common\\ bile\\ and\\/or\\ pancreatic\\ duct\\ and\\ atrophy\\ of\\ pancreatic\\ tissue\\ beyond\\ the\\ tumor\\.\\ the\\ typical\\ distribution\\ of\\ ductal\\ cell\\ adenocarcinoma\\ is\\ as\\ follows\\:\\ 60\\â\\€\\“70\\%\\ at\\ the\\ pancreatic\\ head\\,\\ 10\\%\\ the\\ body\\,\\ 5\\%\\ the\\ tail\\,\\ 5\\%\\ both\\ head\\ and\\ body\\,\\ and\\ about\\ 10\\%\\ body\\ and\\ tail\\ \\[1\\]\\.\\ \ \(0\)\
\-\ those\\ who\\ present\\ with\\ a\\ pancreatic\\ head\\ mass\\ often\\ have\\ symptoms\\ earlier\\ than\\ in\\ those\\ with\\ pancreatic\\ tail\\ masses\\,\\ mainly\\ due\\ to\\ symptomatic\\ obstruction\\ of\\ the\\ biliary\\ or\\ pancreatic\\ duct\\.\\ radiographic\\ assessment\\ of\\ resectability\\ is\\ critical\\ because\\ surgical\\ resection\\ offers\\ the\\ only\\ hope\\ of\\ cure\\[2\\]\\.\\ \\ however\\,\\ the\\ surgery\\ itself\\ carries\\ a\\ high\\ morbidity\\.\\ resectable\\ patients\\ may\\ live\\ 1\\-2\\ years\\.\\ signs\\ of\\ potential\\ resectability\\ include\\ an\\ isolated\\ pancreatic\\ mass\\ with\\ or\\ without\\ dilation\\ of\\ the\\ bile\\ or\\ pancreatic\\ ducts\\ or\\ combined\\ dilation\\ of\\ both\\ the\\ bile\\ and\\ pancreatic\\ ducts\\ without\\ an\\ identifiable\\ pancreatic\\ head\\ mass\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pancreatic\\:\\ 0\\.19078999409116634\ \(0\)\
\-\ tumors\\:\\ 0\\.03821090901988691\ \(0\)\
\-\ \\]\\:\\ 0\\.03548978573105408\ \(0\)\
\-\ \\[\\:\\ 0\\.035387377756165926\ \(0\)\
\-\ non\\-endocrine\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ resectability\\:\\ 0\\.03223163191827997\ \(0\)\
\-\ exocrine\\:\\ 0\\.029481047868438918\ \(0\)\
\-\ contrast\\-enhanced\\:\\ 0\\.02851289722161517\ \(0\)\
\-\ tail\\:\\ 0\\.028003836665435634\ \(0\)\
\-\ \\%\\:\\ 0\\.027685014352027883\ \(0\)\
\-\ body\\:\\ 0\\.027532378102074248\ \(0\)\
\-\ non\\-enhanced\\:\\ 0\\.027260350297266606\ \(0\)\
\-\ bile\\:\\ 0\\.027184661797125826\ \(0\)\
\-\ attenuating\\:\\ 0\\.025121475294359114\ \(0\)\
\-\ indirect\\:\\ 0\\.025121475294359114\ \(0\)\
\-\ ductal\\:\\ 0\\.023976349292764598\ \(0\)\
\-\ mass\\:\\ 0\\.0235805755346739\ \(0\)\
\-\ duct\\:\\ 0\\.023319515619140398\ \(0\)\
\-\ dynamic\\:\\ 0\\.02190349824588162\ \(0\)\
\-\ 1\\:\\ 0\\.020171888571028838\ \(0\)\
\-\ \\#\\:\\ 0\\.01995051558893386\ \(0\)\
\-\ film\\:\\ 0\\.01953648175737487\ \(0\)\
\-\ ducts\\:\\ 0\\.019458315152929968\ \(0\)\
\-\ head\\:\\ 0\\.01923493103630076\ \(0\)\
\-\ assessment\\:\\ 0\\.018238137772977742\ \(0\)\
\-\ hypodense\\:\\ 0\\.018066819630655487\ \(0\)\
\-\ signs\\:\\ 0\\.017901047226107466\ \(0\)\
\-\ unenhancing\\:\\ 0\\.017491107984060512\ \(0\)\
\-\ 60\\â\\€\\“70\\:\\ 0\\.017491107984060512\ \(0\)\
\-\ potential\\:\\ 0\\.0163295161038654\ \(0\)\
\-\ 75\\-85\\:\\ 0\\.016115815959139985\ \(0\)\
\-\ dilation\\:\\ 0\\.015984232861843063\ \(0\)\
\-\ image\\:\\ 0\\.015888030751771434\ \(0\)\
\-\ usually\\:\\ 0\\.01544600151111166\ \(0\)\
\-\ those\\:\\ 0\\.015429621979401958\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.014649025573663646\ \(0\)\
\-\ non\\-functional\\:\\ 0\\.014297778792723011\ \(0\)\
\-\ adenocarcinomas\\:\\ 0\\.014297778792723011\ \(0\)\
\-\ ct\\:\\ 0\\.014229805397524319\ \(0\)\
\-\ shows\\:\\ 0\\.013984367260290944\ \(0\)\
\-\ unresectable\\:\\ 0\\.013936029672100085\ \(0\)\
\-\ offers\\:\\ 0\\.013936029672100085\ \(0\)\
\-\ slightly\\:\\ 0\\.013707247056575686\ \(0\)\
\-\ resectable\\:\\ 0\\.013630175148633303\ \(0\)\
\-\ hope\\:\\ 0\\.013365231909298931\ \(0\)\
\-\ than\\:\\ 0\\.013327671755465915\ \(0\)\
\-\ lethal\\:\\ 0\\.01313153540998071\ \(0\)\
\-\ used\\:\\ 0\\.013008667289476038\ \(0\)\
\-\ peripancreatic\\:\\ 0\\.012922486767802483\ \(0\)\
\-\ 1\\,2\\:\\ 0\\.012922486767802483\ \(0\)\
\-\ bolus\\:\\ 0\\.012922486767802483\ \(0\)\
\-\ cure\\:\\ 0\\.01273337926819073\ \(0\)\
\-\ mm\\:\\ 0\\.01246902839998018\ \(0\)\
\-\ arrow\\:\\ 0\\.012401922751001906\ \(0\)\
\-\ live\\:\\ 0\\.012254883123712776\ \(0\)\
\-\ seventh\\:\\ 0\\.01211799250568311\ \(0\)\
\-\ carries\\:\\ 0\\.01211799250568311\ \(0\)\
\-\ obstruction\\:\\ 0\\.011957936700751728\ \(0\)\
\-\ or\\:\\ 0\\.011922889868615566\ \(0\)\
\-\ tumor\\:\\ 0\\.011858525604826257\ \(0\)\
\-\ liver\\:\\ 0\\.011691355201717157\ \(0\)\
\-\ present\\:\\ 0\\.011488147344831433\ \(0\)\
\-\ atrophic\\:\\ 0\\.011450388861593401\ \(0\)\
\-\ identifiable\\:\\ 0\\.011450388861593401\ \(0\)\
\-\ 10\\:\\ 0\\.01143104852518615\ \(0\)\
\-\ \\)\\:\\ 0\\.011325995112909604\ \(0\)\
\-\ is\\:\\ 0\\.011156563063189\ \(0\)\
\-\ 4\\.3\\:\\ 0\\.01110444960138551\ \(0\)\
\-\ obstructed\\:\\ 0\\.01102663072608138\ \(0\)\
\-\ 2\\:\\ 0\\.010953002955419917\ \(0\)\
\-\ carcinomas\\:\\ 0\\.01087959109879225\ \(0\)\
\-\ often\\:\\ 0\\.010819339478252588\ \(0\)\
\-\ mainly\\:\\ 0\\.010809965464246079\ \(0\)\
\-\ resection\\:\\ 0\\.010575062125080232\ \(0\)\
\-\ method\\:\\ 0\\.010553592981150828\ \(0\)\
\-\ critical\\:\\ 0\\.010553592981150828\ \(0\)\
\-\ endocrine\\:\\ 0\\.010494360911409397\ \(0\)\
\-\ abrupt\\:\\ 0\\.010494360911409397\ \(0\)\
\-\ morbidity\\:\\ 0\\.010326588316115621\ \(0\)\
\-\ only\\:\\ 0\\.010196078009860854\ \(0\)\
\-\ decreased\\:\\ 0\\.01008236667747841\ \(0\)\
\-\ seen\\:\\ 0\\.010051354851593393\ \(0\)\
\-\ decade\\:\\ 0\\.009982795218349676\ \(0\)\
\-\ differentiate\\:\\ 0\\.009982795218349676\ \(0\)\
\-\ never\\:\\ 0\\.009982795218349676\ \(0\)\
\-\ 5\\:\\ 0\\.009921271517635569\ \(0\)\
\-\ mostly\\:\\ 0\\.009894597276740878\ \(0\)\
\-\ average\\:\\ 0\\.009894597276740878\ \(0\)\
\-\ detection\\:\\ 0\\.009851926234635792\ \(0\)\
\-\ beyond\\:\\ 0\\.009851926234635792\ \(0\)\
\-\ window\\:\\ 0\\.009810153597338507\ \(0\)\
\-\ 1\\-2\\:\\ 0\\.009729157576464984\ \(0\)\
\-\ surrounded\\:\\ 0\\.009689866649290023\ \(0\)\
\-\ largest\\:\\ 0\\.009613544663520589\ \(0\)\
\-\ sensitivity\\:\\ 0\\.009576457098020285\ \(0\)\
\-\ ill\\-defined\\:\\ 0\\.009576457098020285\ \(0\)\
\-\ itself\\:\\ 0\\.009540050076853228\ \(0\)\
\-\ include\\:\\ 0\\.009512513841390026\ \(0\)\
\-\ however\\:\\ 0\\.009441936728559802\ \(0\)\
\-\ borders\\:\\ 0\\.009434673439325553\ \(0\)\
\-\ combined\\:\\ 0\\.00936740845584206\ \(0\)\
\-\ 2\\.5\\:\\ 0\\.009178300956230302\ \(0\)\
\-\ cell\\:\\ 0\\.009159685363418596\ \(0\)\
\-\ follows\\:\\ 0\\.009119068886488871\ \(0\)\
\-\ survival\\:\\ 0\\.009090103014621504\ \(0\)\
\-\ tomography\\:\\ 0\\.009061553932375276\ \(0\)\
\-\ axis\\:\\ 0\\.009033409815327744\ \(0\)\
\-\ \\:\\:\\ 0\\.00897043504754496\ \(0\)\
\-\ computed\\:\\ 0\\.008951296291195095\ \(0\)\
\-\ 56\\:\\ 0\\.008924663314345611\ \(0\)\
\-\ isolated\\:\\ 0\\.008821568594244994\ \(0\)\
\-\ atrophy\\:\\ 0\\.008747617414091755\ \(0\)\
\-\ pancreas\\:\\ 0\\.008676323744992423\ \(0\)\
\-\ both\\:\\ 0\\.008659523772563973\ \(0\)\
\-\ rapid\\:\\ 0\\.008562914193722685\ \(0\)\
\-\ biliary\\:\\ 0\\.008562914193722685\ \(0\)\
\-\ earlier\\:\\ 0\\.00837380669411093\ \(0\)\
\-\ majority\\:\\ 0\\.008334122831597695\ \(0\)\
\-\ almost\\:\\ 0\\.008201165073099759\ \(0\)\
\-\ highly\\:\\ 0\\.0081647580519327\ \(0\)\
\-\ \\,\\:\\ 0\\.008056847188014506\ \(0\)\
\-\ \\;\\:\\ 0\\.008037385668462673\ \(0\)\
\-\ direct\\:\\ 0\\.008008720100902715\ \(0\)\
\-\ short\\:\\ 0\\.007992116430921532\ \(0\)\
\-\ 90\\:\\ 0\\.007992116430921532\ \(0\)\
\-\ without\\:\\ 0\\.007984179231580001\ \(0\)\
\-\ imaging\\:\\ 0\\.007944737398633344\ \(0\)\
\-\ 3\\:\\ 0\\.0079403790742323\ \(0\)\
\-\ injection\\:\\ 0\\.00791112041004801\ \(0\)\
\-\ a\\:\\ 0\\.00786904368687701\ \(0\)\
\-\ most\\:\\ 0\\.007828710879873317\ \(0\)\
\-\ nodes\\:\\ 0\\.007658117790407217\ \(0\)\
\-\ 13\\:\\ 0\\.007658117790407217\ \(0\)\
\-\ distribution\\:\\ 0\\.007630367310298606\ \(0\)\
\-\ life\\:\\ 0\\.0073966708109803846\ \(0\)\
\-\ metastases\\:\\ 0\\.007243516765958302\ \(0\)\
\-\ parenchyma\\:\\ 0\\.007220969625779105\ \(0\)\
\-\ \\(\\:\\ 0\\.007166286966704965\ \(0\)\
\-\ and\\/or\\:\\ 0\\.0071656978906541715\ \(0\)\
\-\ limited\\:\\ 0\\.007154825934771979\ \(0\)\
\-\ diameter\\:\\ 0\\.007133259124778121\ \(0\)\
\-\ the\\:\\ 0\\.007131907544234664\ \(0\)\
\-\ surgical\\:\\ 0\\.007127864167664498\ \(0\)\
\-\ are\\:\\ 0\\.006933773050771438\ \(0\)\
\-\ lymph\\:\\ 0\\.006844330176477473\ \(0\)\
\-\ typical\\:\\ 0\\.006798505345535708\ \(0\)\
\-\ measuring\\:\\ 0\\.00678046770327132\ \(0\)\
\-\ symptomatic\\:\\ 0\\.006736078223599627\ \(0\)\
\-\ currently\\:\\ 0\\.006718596815500113\ \(0\)\
\-\ about\\:\\ 0\\.006535828385127483\ \(0\)\
\-\ 7\\:\\ 0\\.006496537457952523\ \(0\)\
\-\ radiographic\\:\\ 0\\.00643524680910463\ \(0\)\
\-\ commonly\\:\\ 0\\.006397879848126272\ \(0\)\
\-\ greater\\:\\ 0\\.006368484836647819\ \(0\)\
\-\ occur\\:\\ 0\\.006361203628534798\ \(0\)\
\-\ 8\\:\\ 0\\.006339518964780452\ \(0\)\
\-\ appears\\:\\ 0\\.006310969882534223\ \(0\)\
\-\ reported\\:\\ 0\\.006180704068602801\ \(0\)\
\-\ calcification\\:\\ 0\\.006154336544557795\ \(0\)\
\-\ because\\:\\ 0\\.005931583961480254\ \(0\)\
\-\ presentation\\:\\ 0\\.005840080623990242\ \(0\)\
\-\ enlarged\\:\\ 0\\.005784962441238108\ \(0\)\
\-\ week\\:\\ 0\\.005757967099857595\ \(0\)\
\-\ less\\:\\ 0\\.005741944453021195\ \(0\)\
\-\ masses\\:\\ 0\\.005731334123008109\ \(0\)\
\-\ available\\:\\ 0\\.005699839382618645\ \(0\)\
\-\ x\\:\\ 0\\.005593385586006899\ \(0\)\
\-\ several\\:\\ 0\\.005450581023258705\ \(0\)\
\-\ severe\\:\\ 0\\.0052168845239404845\ \(0\)\
\-\ diffuse\\:\\ 0\\.0051329512309034025\ \(0\)\
\-\ as\\:\\ 0\\.005129275817040189\ \(0\)\
\-\ in\\:\\ 0\\.005016633692145891\ \(0\)\
\-\ years\\:\\ 0\\.004978657017893814\ \(0\)\
\-\ changes\\:\\ 0\\.004859222175069565\ \(0\)\
\-\ when\\:\\ 0\\.0048558159476508045\ \(0\)\
\-\ lymphoma\\:\\ 0\\.004845632211090249\ \(0\)\
\-\ focal\\:\\ 0\\.004842249214560321\ \(0\)\
\-\ following\\:\\ 0\\.004812059041470532\ \(0\)\
\-\ time\\:\\ 0\\.004788891323887524\ \(0\)\
\-\ an\\:\\ 0\\.0046891462868441655\ \(0\)\
\-\ high\\:\\ 0\\.00463997234340638\ \(0\)\
\-\ months\\:\\ 0\\.004630835902162831\ \(0\)\
\-\ distal\\:\\ 0\\.0046096797399722755\ \(0\)\
\-\ at\\:\\ 0\\.004594298225522353\ \(0\)\
\-\ up\\:\\ 0\\.004559220537805999\ \(0\)\
\-\ cm\\:\\ 0\\.004547531979795606\ \(0\)\
\-\ due\\:\\ 0\\.004524359430461983\ \(0\)\
\-\ common\\:\\ 0\\.004437038118961105\ \(0\)\
\-\ who\\:\\ 0\\.00442057224036052\ \(0\)\
\-\ these\\:\\ 0\\.004412390261821111\ \(0\)\
\-\ patients\\:\\ 0\\.004388044840011956\ \(0\)\
\-\ on\\:\\ 0\\.004308875073603738\ \(0\)\
\-\ more\\:\\ 0\\.004240429185143187\ \(0\)\
\-\ abdominal\\:\\ 0\\.004237934996274038\ \(0\)\
\-\ to\\:\\ 0\\.004236786790108991\ \(0\)\
\-\ symptoms\\:\\ 0\\.0042255108668613865\ \(0\)\
\-\ of\\:\\ 0\\.004160850028499586\ \(0\)\
\-\ surgery\\:\\ 0\\.004117061635635466\ \(0\)\
\-\ upper\\:\\ 0\\.004091429574144282\ \(0\)\
\-\ tissue\\:\\ 0\\.004018692834231337\ \(0\)\
\-\ diagnosis\\:\\ 0\\.003893292322977023\ \(0\)\
\-\ were\\:\\ 0\\.0038497744775593673\ \(0\)\
\-\ contrast\\:\\ 0\\.00379518985477759\ \(0\)\
\-\ may\\:\\ 0\\.0037189054938454834\ \(0\)\
\-\ have\\:\\ 0\\.0036715041237402614\ \(0\)\
\-\ within\\:\\ 0\\.003234387715051749\ \(0\)\
\-\ male\\:\\ 0\\.003065884003744986\ \(0\)\
\-\ for\\:\\ 0\\.002893286304137758\ \(0\)\
\-\ by\\:\\ 0\\.002823156554057291\ \(0\)\
\-\ disease\\:\\ 0\\.0027713046452692543\ \(0\)\
\-\ be\\:\\ 0\\.0026145966733014466\ \(0\)\
\-\ there\\:\\ 0\\.002523245151716247\ \(0\)\
\-\ not\\:\\ 0\\.0024500370471070144\ \(0\)\
\-\ and\\:\\ 0\\.0021429643539549815\ \(0\)\
\-\ pain\\:\\ 0\\.002070651126053045\ \(0\)\
\-\ \\.\\:\\ 0\\.001972196449852571\ \(0\)\
\-\ this\\:\\ 0\\.0019070182803851846\ \(0\)\
\-\ year\\:\\ 0\\.0018970342644303864\ \(0\)\
\-\ left\\:\\ 0\\.0018970342644303864\ \(0\)\
\-\ with\\:\\ 0\\.001857209144283964\ \(0\)\
\-\ right\\:\\ 0\\.0017889518037905092\ \(0\)\
\-\ old\\:\\ 0\\.0017359813429806638\ \(0\)\
\-\ no\\:\\ 0\\.0017072304577456388\ \(0\)\
\-\ patient\\:\\ 0\\.0016995871645166427\ \(0\)\
